Mednet Logo
CommunityMedical Oncology

How do you approach a tumor that has been reported as HER2 amplified based on IHC 3+, but further testing with FISH is negative?

4 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Maryland School of Medicine
Answered on

Treat as Her2 positive. There is no need to do a FISH test if IHC is 3+. Positivity by either method has shown benefit.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Private Practice and Digital Health
Answered on

If IHC is on a core, then I would want to verify by FISH, and test resection specimen to avoid the pitfall of calling HER2+ disease when it is actually a false-positive, especially when we don't review path ourselves. Some clues are low grade, high ER and PR, low proliferation. If HER2+, these tend ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Columbia University Medical Center
Answered on

I would start by repeating the test, and often at another lab. Just to be sure that the results are robust. We often see discrepancies from lab to lab. If confirmed, i would treat as Her-2 Positive if the IHC was truly 3+. Many of the patients that were enrolled on the trials that led to FDA approva...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Medical Oncology · Sarah Cannon Cancer Institute at Menorah Medical Center
Answered on

ASCO/CAP just released their updated guidelines

http://ascopubs.org/doi/full/10.1200/JCO.2018.77.8738

Join for free or sign in to see the full answer